TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

TCV Vaccines Market, By Vaccine Brand (Ty21a (Vivotif), ViCPS (Typhim Vi), Vi-TT (Peda-typhTM), and Typbar TCV), By Distribution Channel (Public and Private), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)


The TCV vaccines market has been witnessing steady growth over the past few years due to increasing incidence of diseases and infections. TCV vaccines target tetanus, diphtheria, and pertussis/whooping cough which are highly infectious bacterial respiratory diseases. Pertussis is especially dangerous for infants and young children which has been a key factor driving vaccination programs globally. While tetanus and diphtheria vaccination rates are high worldwide, pertussis continues to spread in schools and communities necessitating regular booster doses. Growing awareness about benefits of immunization and government efforts to strengthen routine immunization programs in developing countries have boosted market revenues. Recent new product approvals and large clinical trials evaluating expansion of indication have further widened growth opportunities in this market.

Market Dynamics:

TCV vaccines market is expected to witness robust growth going forward on account of rising demand from developing regions and increasing coverage of vaccination programs worldwide. The key drivers fueling the market include growing awareness among parents, expanding recommendation by international health organizations to protect vulnerable population groups, and government subsidies and funding in low and middle income nations. However, high costs associated with R&D, manufacturing, and distribution of combination vaccines pose a major challenge to adoption rates. In addition, ongoing vaccine hesitancy due to misinformation and religious beliefs inhibits market potential in some countries.

Key Features of the Study:
  • This report provides in-depth analysis of the global TCV vaccines market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2024–2031), considering 2023 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global TCV vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GSK plc., Sanofi, Bharat Biotech, BioFarma, Zydus Group, Emergent BioSolutions Inc., Bavarian Nordic Inc., Crucell Switzerland LTD., PaxVax, Inc., and BIO-MED
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global TCV vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global TCV vaccines market
Market Segmentation
  • By Vaccine Brand Insights (Revenue, USD Mn, 2019 - 2031)
  • Ty21a (Vivotif)
  • ViCPS (Typhim Vi)
  • Vi-TT (Peda-typhTM)
  • Typbar TCV
  • By Distribution Channel Insights (Revenue, USD Mn, 2019 - 2031)
  • Public
  • UNICEF
  • Tender (Govt.)
  • Private
  • Regional Insights (Revenue, USD Mn, 2019 - 2031)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
  • Key Players Insights
  • GSK plc.
  • Sanofi
  • Bharat Biotech
  • BioFarma
  • Zydus Group
  • Emergent BioSolutions Inc.
  • Bavarian Nordic Inc.
  • Crucell Switzerland LTD.
  • PaxVax, Inc.
  • BIO-MED


1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
TCV Vaccines Market, By Vaccine Brand
TCV Vaccines Market, By Distribution Channel
TCV Vaccines Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER’s Analysis
Merger and Acquisition Scenario
Market Trends
Epidemiology
4. Global TCV Vaccines Market, By Vaccine Brand, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Ty21a (Vivotif)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
ViCPS (Typhim Vi)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Vi-TT (Peda-typhTM)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
Typbar TCV
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global TCV Vaccines Market, By Distribution Channel, 2019-2031, (USD Mn)
Introduction
Market Share Analysis, 2024 and 2031 (%)
Y-o-Y Growth Analysis, 2020 - 2031
Segment Trends
Public
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
UNICEF
Tender (Govt.)
Private
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global TCV Vaccines Market, By Region, 2019 - 2031, Value (USD Mn)
Introduction
Market Share (%) Analysis, 2024,2027 & 2031, Value (USD Mn)
Market Y-o-Y Growth Analysis (%), 2020 - 2031, Value (USD Mn)
Regional Trends
North America
Introduction
Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
U.S.
Canada
Latin America
Introduction
Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Introduction
Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
Introduction
Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Country, 2019 - 2031, Value (USD Mn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, By Vaccine Brand, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Distribution Channel, 2019 - 2031, Value (USD Mn)
Market Size and Forecast, By Country/Region, 2019 - 2031, Value (USD Mn)
South Africa
North Africa
Central Africa
7. Competitive Landscape
GSK plc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Sanofi
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bharat Biotech
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
BioFarma
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Zydus Group
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Emergent BioSolutions Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Bavarian Nordic Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
Crucell Switzerland LTD.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
PaxVax, Inc.
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
BIO-MED
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
8. Analyst Recommendations
Wheel of Fortune
Analyst View
Coherent Opportunity Map
9. References and Research Methodology
References
Research Methodology
About us
*Browse 32 market data tables and 28 figures on 'TCV Vaccines Market' - Global forecast to 2031

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings